DMRA — ACORDA THERAPEUTICS INC
As of Q2 2026, 1 SEC-registered investment managers reported holding DMRA (ACORDA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $1.27K across 48.74K shares. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
DMRA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Davidson Kempner Capital Management history | Q1 2024 | 52.32M | $23.12M | 0.44% | Hold |
| Soros Fund Management history | Q1 2024 | 27.95M | $15.93M | 0.34% | Hold |
| D. E. Shaw & Co history | Q1 2024 | 14.00M | $8.15M | 0.01% | Hold |
| Wells Fargo & Co history | Q1 2024 | 5.02M | $2.86M | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 48.74K | $1.27K | 0.00% | New |
New Positions (Q2 2026)
- T. Rowe Price Associates 48.74K sh · $1.27K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 5 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates | — | — | — | — | — | — | — | — | — | — | — | 48.74K |
| Soros Fund Management | 28.00M | 28.00M | 28.00M | 28.00M | 28.00M | 28.00M | 28.00M | 28.00M | 27.95M | 27.95M | 27.95M | — |
| Davidson Kempner Capital Management | 48.32M | 48.32M | 50.32M | 52.32M | 52.32M | 52.32M | 52.32M | 52.32M | 52.32M | 52.32M | 52.32M | — |
| D. E. Shaw & Co | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | 14.00M | — |
| Wells Fargo & Co | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | 5.02M | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details